Rize Oncology Inc.
RZONF
$0.16
$0.1639,900.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.21M | -965.40K | -672.30K | -550.90K | -696.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.40K | 57.00K | 41.50K | 26.80K | 265.90K |
| Change in Net Operating Assets | 31.20K | -142.20K | -246.50K | -72.10K | -92.40K |
| Cash from Operations | -1.14M | -1.05M | -877.40K | -596.30K | -523.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 347.50K | 347.50K | 347.50K | 347.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 347.50K | 347.50K | 347.50K | 347.50K | -- |
| Foreign Exchange rate Adjustments | -700.00 | -23.90K | -78.50K | -109.00K | -28.10K |
| Miscellaneous Cash Flow Adjustments | -22.90K | 9.00K | 9.00K | 9.00K | 9.00K |
| Net Change in Cash | -814.20K | -718.10K | -599.40K | -348.80K | -542.60K |